Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate

Arthritis & Rheumatism

Volumn 28, Issue 11, 1985, Pages 1243-1250

  Jungers, Paul ^a   Kuttenn, Frédérique ^a   Liote, Frédéric ^a   Pelissier, Clara ^a   Athea, Nicole ^a   Laurent, Marie‐Christine ^a   Viriot, Joëlle ^a   Dougados, Maxime ^a   Bach, Jean‐François ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ESTRADIOL; SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

CLINICAL ARTICLE; DRUG THERAPY; ENDOCRINE SYSTEM; HUMAN; JOINT; ORAL DRUG ADMINISTRATION; PLASMA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY;

ADULT; ANTIMALARIALS; CYPROTERONE; ESTRADIOL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0022347938     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780281108     Document Type: Article

References (31)

1. Lupus nephropathy and pregnancy: report of 104 cases in 36 patients
2. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus
3. Sex hormone modulation of autoimmunity in NZB/NZW mice
4. Approach to the study of the role of sex hormones in autoimmunity
5. Increasd 16 alpha‐hydroxylation of estradiol in systemic lupus erythematosus
6. Low plasma androgens in women with active or quiescent systemic lupus erythematosus
7. Increased oxidation of testosterone in systemic lupus erythematosus
8. Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19‐nortestosterone
9. Preliminary observation on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement
10. Pharmacology and potential use of cyproterone acetate
11. Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol
12. The effect of cyproterone acetate on pituitaryovarian function and clinical symptoms in hirsute women
13. Synandrogenic and antiandrogenic effect of progestins: comparison with nonprogestational antiandrogens
14. Androgenic, antiandrogenic, and synandrogenic action of progestins: role of steric and allosteric interactions with androgen receptors
15. Sex specific action of antiandrogens on androgen induced changes in hepatic microsomial 3 beta‐hydroxysteroid dehydrogenase and 5 alphareductase activity in the rat
16. Antiandrogens in the treatment of acne and hirsutism
17. The 1982 revised criteria for the classification of systemic lupus erythematosus
18. Further characterization and immunological studies of human sex steroid binding plasma protein
19. Immunologic sex differences and the female predominance in systemic lupus erythematosus
20. Androgenic status of males with systemic lupus erythematosus
21. The effects of nandrolone, testosterone and their decanoate esters on murine lupus
22. 1 mice
23. Systemic lupus erythematosus: two patients treated with danazol
24. Danazol in systemic lupus erythematosus: a two years prospective controlled trial in 40 female patients (abstract)
25. Traitement de l'hirsutisme par l'acétate de cyprotérone et l'estradiol percutané
26. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate
27. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate
28. Androgen receptor in human skin cytosol
29. Danazol
30. Evidence for a specific dihydrotestosterone‐binding cytosol receptor in the human prostate
31. Exacerbation of a lupus erythematosus‐like syndrome during treatment of non‐Clesterase inhibitor‐dependent angioedema with danazol